Northeast Financial Consultants’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,483
| Closed | -$52K | – | 344 |
|
|
2022
Q3 | $52K | Hold |
12,483
| – | – | ﹤0.01% | 329 |
|
|
2022
Q2 | $50K | Hold |
12,483
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $62K | Sell |
12,483
-1,532
| -11% | -$7.61K | ﹤0.01% | 383 |
|
|
2021
Q4 | $98K | Hold |
14,015
| – | – | 0.01% | 349 |
|
|
2021
Q3 | $140K | Buy |
+14,015
| New | +$140K | 0.01% | 342 |
|